EGFR and breast carcinoma: In some cases, these changes lead to overexpression of membrane molecules, such as the receptor tyrosine kinase-like orphan receptor 1 (ROR1) and the epidermal growth factor receptor (EGFR), which are found in breast cancer, lung adenocarcinoma, and glioblastoma (8–12) and are considered promising therapeutic targets.